Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)
Tolaney, SM, Barry, WT, Dang, CT, Yardley, DA, Moy, B, Marcom, PK, Albain, KS, Rugo, HS, Ellis, M, Shapira, I, Wolff, AC, Carey, LA, Overmoyer, BA, Partridge, AH, Guo, H, Hudis, CA, Krop, IE, Burstein, HJ, Winer, EP
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics
Lipton, A, Fizazi, K, Stopeck, A.T, Henry, D.H, Smith, M.R, Shore, N, Martin, M, Vadhan-Raj, S, Brown, J.E, Richardson, G.E, Saad, F, Yardley, D.A, Zhou, K, Balakumaran, A, Braun, A
Published in European journal of cancer (1990) (01.01.2016)
Published in European journal of cancer (1990) (01.01.2016)
Get full text
Journal Article
Abstract P6-17-36: Consensus and disagreement among experts for treatment of patients with HER2+ early-stage breast cancer suggests unmet need for online decision support tool
Holmes, FA, Rosenthal, KM, Hurvitz, S, Pegram, MD, Yardley, DA, Obholz, KL, O'Shaughnessy, J
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P6-18-15: Ribociclib + endocrine therapy in hormone receptor-positive, HER2-negative advanced breast cancer: A pooled safety analysis
Burris, HA, Chan, A, Im, S-A, Chia, S, Tripathy, D, Esteva, FJ, Campone, M, Bardia, A, Kong, O, Bao, W, Diaz-Padilla, I, Rodriguez Lorenc, K, Yardley, DA
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract OT2-06-04: MORPHEUS: A phase Ib/II trial platform evaluating the safety and efficacy of multiple cancer immunotherapy combinations in patients with hormone receptor–positive and triple-negative breast cancer
Yardley, DA, Abu-Khalaf, M, Boni, V, Brufsky, A, Emens, LA, Gutierrez, M, Hurvitz, S, Im, S-A, Loi, S, McCune, SL, Schmid, P, O'Hear, C, Zhang, X, Vidal, GA
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P4-22-04: A randomized, double-blind, phase 2 study of ruxolitinib (RUX) or placebo (PBO) in combination with capecitabine (CAPE) in patients (pts) with advanced HER2-negative breast cancer (ABC) and elevated C-reactive protein (CRP), a marker of systemic inflammation
O'Shaughnessy, J, DeMichele, A, Ma, C, Richards, P, Yardley, DA, Wright, G, Kalinsky, K, Steis, R, Diab, S, Kennealey, G, Geschwindt, R, Jiang, W, Rugo, H
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract OT2-01-05: TRINITI-1: Ribociclib + everolimus (EVE) + exemestane (EXE) triplet combination in men or postmenopausal women with HR+, HER2– advanced breast cancer (ABC) following progression on a cyclin-dependent kinase (CDK) 4/6 inhibitor
Bardia, A, Hurvitz, S, Yardley, DA, Zelnak, A, DeMichele, A, Clark, AS, Warsi, G, Small, T, Tucci, C, Moulder, S
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P1-01-16: Circulating tumor cells (CTCs) biomarker evaluation from patients with metastatic breast cancer (MBC) utilizing the TargetSelectorTM platform
Hamilton, EP, Yardley, DA, Burris III, HA, Shastry, M, Huynh, L, Bhikha, L, Singh, VM
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract OT3-05-06: EarLEE-2: A phase 3 study of ribociclib + endocrine therapy (ET) for adjuvant treatment of patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), intermediate-risk, early breast cancer (EBC)
O'Shaughnessy, J, Alba, E, Bardia, A, Dent, S, Dieras, V, Hortobagyi, G, Im, S-A, Montemurro, F, Untch, M, Yardley, DA, Chakravartty, A, Germa, C, Miller, M, Slamon, D
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract P6-20-01: METRIC: A randomized international phase 2b study of the antibody-drug conjugate (ADC) glembatumumab vedotin (GV) in gpNMB-overexpressing, metastatic, triple-negative breast cancer (mTNBC)
Vahdat, LT, Forero-Torres, A, Schmid, P, Blackwell, K, Telli, ML, Melisko, M, Holgado, E, Moebus, V, Cortes, J, Fehrenbacher, L, Montero, AJ, Ma, C, Nanda, R, Wright, GS, He, Y, Bagley, RG, Halim, A, Turner, CD, Yardley, DA
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P6-18-07: Ribociclib + endocrine therapy in patients with hormone receptor-positive, HER2-negative advanced breast cancer presenting with visceral metastases: Subgroup analysis of phase III MONALEESA trials
Yardley, DA, Chan, A, Nusch, A, Sonke, GS, Yap, Y-S, Bachelot, T, Esteva, FJ, Slamon, DJ, Burris, HA, Gaur, A, Kong, O, Diaz-Padilla, I, Rodriguez Lorenc, K, Wheatley-Price, P
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P5-09-04: Consensus and disagreement between experts and community practitioners asked to make therapeutic recommendations for early breast cancer (EBC)
Obholz, KL, Rosenthal, KM, O'Regan, RM, Swain, SM, Yardley, DA, Brady, ED
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P5-08-27: Treatment patterns and clinical outcomes in patients with hormone receptor (HR)+ HER2+ metastatic breast cancer and low vs high levels of HR positivity from the SystHERs Registry
Jahanzeb, M, Tripathy, D, Rugo, H, Swain, S, Kaufman, PA, Mayer, M, Hurvitz, S, O'Shaughnessy, J, Mason, G, Yardley, DA, Brufsky, A, Chu, L, Antao, V, Beattie, M, Yoo, B, Cobleigh, M
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P4-22-09: A phase 2 open label study of everolimus in combination with endocrine therapy in resistant hormone receptor-positive HER2-negative advanced breast cancer
Yardley, DA, Blakely, L, Hemphill, B, Joseph, M, Liggett, W, Daniel, B, Castrellon, A, Shastry, M, Finney, L, DeBusk, L, Hainsworth, JD, Burris, HA
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P5-08-08: Baseline (BL) characteristics, treatment (tx) patterns, and outcomes in patients with hormone receptor (HR)+ vs HR– HER2+ disease from the SystHERs registry
Cobleigh, M, Yardley, DA, Brufsky, A, Rugo, H, Swain, S, Kaufman, PA, Tripathy, D, Mayer, M, Hurvitz, S, O'Shaughnessy, J, Mason, G, Chu, L, Antao, V, Beattie, M, Yoo, B, Jahanzeb, M
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P5-21-27: Efficacy and safety of ribociclib plus letrozole in US patients enrolled in the MONALEESA-2 study
Yardley, DA, Hart, L, Favret, A, Blau, S, Diab, S, Richards, D, Sparano, J, Beck, JT, Richards, P, Ward, P, Ramaswamy, B, Tsai, M, Pluard, T, Tolaney, S, Esteva, F, Small, T, Purkayastha, D, Miller, M, Hortobagyi, G
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract PD5-11: Not presented
Bardia, A, Yardley, DA, Hurvitz, S, Wright, G, Moroose, R, Ma, C, Hart, L, Tan-Chiu, E, Blau, S, Sanft, T, Dichmann, R, Zelnak, A, DeMichele, A, Clark, A, Small, T, Tucci, C, Samant, TS, Purkayastha, D, Karuturi, M, Moulder, S
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract GS4-07: Results from a randomized placebo-controlled phase 2 trial evaluating exemestane ± enzalutamide in patients with hormone receptor–positive breast cancer
Krop, I, Abramson, V, Colleoni, M, Traina, T, Holmes, F, Estevez, L, Hart, L, Awada, A, Zamagni, C, Morris, P, Schwartzberg, L, Chan, S, Wheatley, D, Gucalp, A, Biganzoli, L, Steinberg, J, Gianni, L, Trudeau, M, Tudor, IC, Markova, D, Barry, E, Tarazi, J, Stewart, R, Winer, E, Yardley, DA
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article